We are live on ! Find out more
NRC

North Run Capital Portfolio holdings

AUM $43.5M
1-Year Est. Return 38.24%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$44.2M
Cap. Flow
-$5.04M
Cap. Flow %
-0.49%
Top 10 Hldgs %
64.97%
Holding
33
New
3
Increased
10
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
INXN
Interxion Holding N.V.
INXN
+$37.6M
2
TIBX
TIBCO SOFTWARE INC
TIBX
+$29.6M
3
GIMO
Gigamon Inc.
GIMO
+$22M
4
XXIA
Ixia
XXIA
+$18.6M
5
NRF
NorthStar Realty Finance Corp.
NRF
+$11.6M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$32.6M
2
SIR
SELECT INCOME REIT
SIR
+$30.3M
3
ATI icon
ATI
ATI
+$19.4M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$16.1M
5
HSP
HOSPIRA INC
HSP
+$14.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.17%
2 Consumer Discretionary 20.46%
3 Financials 10.44%
4 Communication Services 8.74%
5 Industrials 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INXN
1
DELISTED
Interxion Holding N.V.
INXN
$89.9M 8.74%
3,282,893
+1,442,693
+78% +$37.6M
BKD icon
2
Brookdale Senior Living
BKD
$3.49B
$85M 8.27%
2,550,000
+350,000
+16% +$11.4M
TIBX
3
DELISTED
TIBCO SOFTWARE INC
TIBX
$80.6M 7.84%
3,995,700
+1,485,850
+59% +$29.6M
HRB icon
4
H&R Block
HRB
$5.58B
$72.9M 7.09%
2,175,000
+200,000
+10% +$5.96M
HNT
5
DELISTED
HEALTH NET INC
HNT
$72.5M 7.05%
1,745,000
– –
ETFC
6
DELISTED
E*Trade Financial Corporation
ETFC
$57.1M 5.55%
2,684,154
+134,154
+5% +$2.82M
GM icon
7
General Motors
GM
$80.4B
$56.3M 5.47%
1,550,000
-245,000
-14% -$8.54M
HSP
8
DELISTED
HOSPIRA INC
HSP
$52.7M 5.12%
1,025,000
-305,400
-23% -$14.5M
NRF
9
DELISTED
NorthStar Realty Finance Corp.
NRF
$50.8M 4.94%
1,489,556
+369,206
+33% +$11.6M
AET
10
DELISTED
Aetna Inc
AET
$50.3M 4.89%
620,000
+30,000
+5% +$2.27M
VC icon
11
Visteon
VC
$2.79B
$49.5M 4.81%
510,000
-80,000
-14% -$7.26M
ATI icon
12
ATI
ATI
$25.6B
$48.5M 4.72%
1,075,000
-475,000
-31% -$19.4M
TEVA icon
13
Teva Pharmaceuticals
TEVA
$40.8B
$45.1M 4.38%
860,000
-315,000
-27% -$16.1M
MOS icon
14
The Mosaic Company
MOS
$7.03B
$44.3M 4.3%
895,000
– –
XXIA
15
DELISTED
Ixia
XXIA
$28.3M 2.75%
2,475,000
+1,522,265
+160% +$18.6M
NETI
16
DELISTED
Eneti Inc.
NETI
$24M 2.34%
24,210
+4,483
+23% +$4.55M
GIMO
17
DELISTED
Gigamon Inc.
GIMO
$23.3M 2.27%
+1,216,800
New +$22M
NRF
18
CALL
DELISTED
NorthStar Realty Finance Corp.
NRF
$18.6M 1.81%
+544,541
New +$17.1M
NWY
19
DELISTED
New York & Co Inc
NWY
$14.7M 1.43%
3,995,973
– –
ALIM
20
DELISTED
Alimera Sciences
ALIM
$11.7M 1.13%
130,000
+22,295
+21% +$1.98M
PRGS icon
21
Progress Software
PRGS
$1.66B
$10.7M 1.04%
443,900
-206,100
-32% -$4.5M
LOV
22
DELISTED
Spark Networks SE American Depositary Shares
LOV
$10.5M 1.02%
1,855,856
– –
EYPT icon
23
EyePoint Inc
EYPT
$1.03B
$9.3M 0.91%
214,409
– –
LORL
24
DELISTED
Loral Space and Communications, Inc.
LORL
$7.27M 0.71%
100,000
– –
CPS icon
25
Cooper-Standard Automotive
CPS
$523M
$6.47M 0.63%
97,852
– –
1
2

Similar funds

ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
BGP
BrandyTrust Global Partners Hockessin, Delaware $35.4M AUM
EOCM
Energy Opportunities Capital Management Austin, Texas $34.4M AUM 54.2% 1-Year Est. Return
SJIA
St. James Investment Advisors Port Jefferson, New York $54.6M AUM 0.39% 1-Year Est. Return
LN
Lewin Nick $31.5M AUM

North Run Capital's Q2 2014 Portfolio in Review

As of Q2 2014, North Run Capital held 33 positions worth $1.03B, up 4.5% from $984M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

North Run Capital's Q2 2014 filing shows 3 new, 10 increased, 8 reduced and 5 closed positions. Its largest new stake was Gigamon Inc.: 1,216,800 shares worth $23.3M. The largest sale was Boston Scientific, an estimated $32.6M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Financials.

  • North Run Capital's largest Q2 2014 buy was Gigamon Inc.: 1,216,800 shares worth $23.3M.
  • North Run Capital added most to Interxion Holding N.V. in Q2 2014, an estimated $37.6M increase.
  • North Run Capital's biggest Q2 2014 reduction was Boston Scientific, cutting an estimated $32.6M.
  • North Run Capital fully exited SELECT INCOME REIT in Q2 2014, selling an estimated $30.3M.
  • North Run Capital's ten largest holdings make up 65% of its $1.03B portfolio in Q2 2014.
  • North Run Capital opened 3 new positions and closed 5 in Q2 2014.
  • North Run Capital's portfolio value rose 4.5% quarter-over-quarter to $1.03B.

Based on North Run Capital's 13F filing for Q2 2014, filed 14 Aug 2014.